She noted the survival benefit with the combination was achieved even though 38% of patients in the enzalutamide-alone arm ...

Opens in a new tab or window SAN FRANCISCO -- Adding talazoparib (Talzenna) to enzalutamide (Xtandi ... Nektar, ORIC Pharmaceuticals, Pfizer, and Takeda. Fizazi reported relationships with ...

This study was sponsored by Pfizer, Inc. Astellas Pharma Inc. provided enzalutamide. Agarwal had disclosed relationships with Pfizer, Janssen, Bayer, Amgen, and others. Kelly had disclosed ...

Opens in a new tab or window SAN FRANCISCO -- The addition of radionuclide therapy with 177 Lu-PSMA-617 (Pluvicto) to enzalutamide ... from Novartis and Clarity Pharma; consulting fees for ...